Shenzhen YHLO Biotech Co Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Shenzhen YHLO Biotech Co
Access all reports
Shenzhen YHLO Biotech Co., Ltd., founded in 2008, is a Chinese company primarily focused on the research, development, manufacture, and sale of in-vitro diagnostic equipment and supporting reagents. The company's extensive product portfolio includes instruments and reagents based on chemiluminescence immunoassay, immunoblotting, enzyme-linked immunoassay, and immunofluorescence chromatography. These products are used in various medical fields, including autoimmunity, reproductive health, diabetes, and infectious diseases. The company is headquartered in Shenzhen, China, and its shares are listed on the Shanghai Stock Exchange.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
688575
Country
🇨🇳 China